AI-generated summary
In a mouse study of experimental stroke induced by photothrombosis, the authors report that low-level light emitting diode therapy started during the subacute stage improved motor function up to 28 days after ischemia. They describe increases in some proliferating brain cell types and in brain-derived neurotrophic factor, but no recovery of brain atrophy was observed, and the results come from an animal model.
- Who or what was studied
- Mice with focal cerebral ischemia induced via photothrombosis, assigned to sham, vehicle, or LED-T groups with treatment initiated acutely, subacutely, or at a delayed time point.
- Limits stated in the abstract
- The study was conducted in mice, so the findings may not apply to humans, and the abstract does not state the number of animals per group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Stroke, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.